METASTATIC CUTANEOUS MELANOMA
Clinical trials for METASTATIC CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a newer immunotherapy drug keep melanoma from coming back?
Disease control OngoingThis phase III trial compares the drug pembrolizumab (MK-3475) to the current standard treatments—high-dose interferon or ipilimumab—in 1,301 patients with high-risk melanoma that has been surgically removed. The goal is to see if pembrolizumab is better at preventing the cancer …
Matched conditions: METASTATIC CUTANEOUS MELANOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
Could a High-Fat diet help cancer immunotherapy work better?
Disease control TerminatedThis early-phase trial is testing whether a ketogenic diet (low carbs, high fat) can safely help immunotherapy drugs work better in people with advanced melanoma or kidney cancer. About 60 participants will follow the diet while receiving standard immunotherapy. The main goals ar…
Matched conditions: METASTATIC CUTANEOUS MELANOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC